3D prostate histology reconstruction: an evaluation of image-based and fiducial-based algorithms

Imaging may enable the determination of the spatial distribution and aggressiveness of prostate cancer in vivo before treatment, possibly supporting diagnosis, therapy selection, and focal therapy guidance. 3D reconstruction of prostate histology facilitates the validation of such imaging applications. We evaluated four histology–ex vivo magnetic resonance (MR) image 3D reconstruction algorithms comprising two similarity metrics (mutual information MMI or fiducial registration error MFRE) and two search domains (affine transformations TA or fiducial-constrained affine transformations TF). Seven radical prostatectomy specimens were imaged with MR imaging, processed for whole-mount histology, and digitized as histology images. The algorithms were evaluated on the reconstruction error and the sensitivity of same to translational and rotational errors in initialization. Reconstruction error was quantified as the target registration error (TRE): the post-reconstruction distance between homologous point landmarks (7–15 per histology section; 132 total) identified on histology and MR images. Sensitivity to initialization was quantified using a linear model relating TRE to varied levels of translational/rotational initialization errors. The algorithm using MMI and TA yielded a mean TRE of 1.2±0.7 mm when initialized using an approach that assumes histology corresponds to the front faces of tissue blocks, but was sensitive to initialization error. The algorithm using MFRE and TA yielded a mean TRE of 0.8±0.4 mm with minimal sensitivity to initialization errors. Compared to the method used to initialize the algorithms (mean TRE 1.4±0.7 mm), a study using an algorithm with a mean TRE of 0.8 mm would require 27% fewer subjects for certain imaging validation study designs.

[1]  R. Tiling,et al.  Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  A. Fenster,et al.  Image-guided prostate sectioning supporting registration of graded cancerous foci from digital histopathology images to in vivo MRI: an interactive 3D visualization tool , 2011, Medical Imaging.

[3]  Jeffrey C. Lagarias,et al.  Convergence Properties of the Nelder-Mead Simplex Method in Low Dimensions , 1998, SIAM J. Optim..

[4]  Aaron Fenster,et al.  Registration Accuracy: How Good Is Good Enough? A Statistical Power Calculation Incorporating Image Registration Uncertainty , 2012, MICCAI.

[5]  Peter Choyke,et al.  Challenges in clinical prostate cancer: role of imaging. , 2009, AJR. American journal of roentgenology.

[6]  Guy Marchal,et al.  Multimodality image registration by maximization of mutual information , 1997, IEEE Transactions on Medical Imaging.

[7]  Miguel Srougi,et al.  Upgrading the Gleason score in extended prostate biopsy: implications for treatment choice. , 2009, International journal of radiation oncology, biology, physics.

[8]  M. Kattan,et al.  Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.

[9]  Aaron Fenster,et al.  Validation of Direct Registration of Whole-Mount Prostate Digital Histopathology to ex vivo MR Images , 2011, Prostate Cancer Imaging.

[10]  R. Ellis,et al.  Fused radioimmunoscintigraphy for treatment planning. , 2006, Reviews in urology.

[11]  Choon Hua Thng,et al.  Optimum slicing of radical prostatectomy specimens for correlation between histopathology and medical images , 2010, International Journal of Computer Assisted Radiology and Surgery.

[12]  Yousef Mazaheri,et al.  Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. , 2011, Radiology.

[13]  J R Thornbury,et al.  Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. , 1996, AJR. American journal of roentgenology.

[14]  P. Waldenberger,et al.  18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients. , 2010, Radiology.

[15]  Daniel O Scharfstein,et al.  Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. , 2005, Urology.